Clinical trial
The Study to Evaluate the Safety and Efficacy of Spinal Cord Stimulation on Progressive Supranuclear Palsy
NCT04367116 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study to Evaluate the Safety and Efficacy of Spinal Cord Stimulation on Progressive Supranuclear Palsy
- Lead sponsor
- Huashan Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 1, 2021
- Completion date
- December 27, 2023
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
progressive supranuclear palsy, spinal cord stimulation